Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases. (2025). Journal of Medicine and Life Sciences, 1(2), 63-69. https://doi.org/10.71222/bc9c9s73